Feed NASC
NA

Nascent Pharma Holdings, Inc.

NASC · OTC

$0.01 -13.94% (-$0.00)
1M +7.83%
Market Cap $910.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
-
N/A
EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A
Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A
Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average
ROA 3,406.45%
Asset turnover 0.00x
ROIC 107.66%
Debt
50 /100
Moderate
Int. coverage -4.50x
Net debt/EBITDA -1.08x
Current ratio 0.02x
Stability
55 /100
Moderate
Rev. volatility 76.26%
EPS volatility 15.06%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o NASC
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Marco Alfonsi

Employees

12

Headquarters

Hicksville

Prihajajoči dogodki

06 NOV.

Earnings

Upcoming earnings report

45d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.